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MATRIX BOUND FGF2 IN CARTILAGE
MECHANOTRANSDUCTION
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Kennedy Institute of Rheumatology, London, United Kingdom
Purpose: Background: Mechanical stimulation of articular carti-
lage is essential for normal joint maintenance and development,
as well as being a recognised risk factor in the development
of osteoarthritis. Whilst investigating the response of articular
cartilage to simple cutting and explantation, we observed the
release of a soluble factor which was a strong activator of the
extracellularly regulated kinase (ERK), one of the three mitogen
activated protein (MAP) kinases. This factor was identiﬁed by
mass spectrometry as basic FGF, also known as FGF2. We
subsequently showed that FGF2 activated ERK in chondrocytes
following cyclical loading, indicating that it mediated an important
tissue response after both injurious and non-injurious mechan-
ical stimuli. Using confocal microscopy and surface plasmon
resonance, we determined that FGF2 was bound to the heparan
sulphate chains of perlecan in the pericellular matrix of articular
cartilage, and that ERK activation upon loading was dependent
upon the concentration of pericellular FGF2.
Aim of the study: To determine the function of matrix bound
FGF2 in articular cartilage.
Methods: We studied the susceptibility of mice with and with-
out deletion of Fgf2 to cartilage degeneration with age, and
following surgical destabilisation of the medial meniscus. RNA
was extracted from joints of animals following surgery and PCR
performed to determine expression levels of key regulatory and
catabolic molecules. Hip explants from 4 week old mice were
stimulated in vitro with IL-1 +/- FGF2 and aggrecanolysis mea-
sured by DMMB and aggrecanase neoepitope assays.
Results: Fgf2-/- mice were morphologically indistinguishable
from wild-type animals and histomorphometric analysis at 3
months of age, revealed no differences in cartilage thickness
or intensity of proteoglycan staining. Nanoindentation studies by
atomic force microscopy showed no changes in the mechanical
properties of the tissue. Ageing studies did reveal accelerated
spontaneous cartilage degeneration in 6 and 9 month old animals
compared to wild type mice, and there was a signiﬁcant increase
in degeneration following surgical destabilisation of the medial
meniscus. Surgically-induced OA in Fgf2-/- mice was suppressed
to wild type levels by subcutaneous administration of recombinant
FGF2 indicating that FGF2 was acting as a chondroprotective
agent in mature articular cartilage.Increased disease in Fgf2-/-
mice was associated with increased expression of ADAMTS5, the
key murine aggrecanase, but not other matrix metalloproteinases
(MMPs), such as MMP13 and ADAMTS4. To test whether FGF2
was able to suppress ADAMTS5 expression in vitro, we stim-
ulated hip explants from wild type mice with interleukin-1. IL-1
induced aggrecanolysis and increased ADAMTS5 expression
which was suppressed by exogenous FGF2 by 50%.
Conclusions: These data identify FGF2 as a novel endogenous
inhibitor of aggrecan breakdown acting through suppression of
ADAMTS5. By inference, these data suggest that, through deliv-
ery of FGF2, joint loading is chondroprotective.
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Meniscectomy is the most frequent orthopaedic procedure, with
at least 450,000 procedures performed in the US yearly. Os-
teoarthritis (OA) follows meniscectomy in about every other pa-
tient after 10-15 years. OA development after meniscectomy is
thought to depend on the loss of meniscal function; i.e. shock
absorption and load transmission. This may constitute a major
cause of OA in the young patient with a meniscal tear in a
healthy knee. However, during the last decade emerging evi-
dence suggests that genetic factors and environment interact
and that meniscal tears often are a sign of incipient OA already
in the middle-aged. Intra-articular evidence includes meniscec-
tomized subjects having more OA also in the other knee and in
the hand, and MRI-veriﬁed meniscal tears being very common
in the elderly population. This has implications for our thinking of
OA prevention and for our treatment of meniscal tears.
Most patients do not recover as expected after meniscal surgery.
Although pain is relieved and self-reported function improved,
cross-sectional studies imply that patients do not reach the level
of matched controls or population-based samples, neither in the
immediate post-operative phase nor during the 20 years to come.
Pain, functional limitations and objectively assessed impaired
muscle function are features that post-meniscectomy patients
share with OA patients. Considering the role of pain and muscle
weakness as predictors of OA, these ﬁndings support that a
meniscal tear may signal OA and that patients with meniscal tear
may substantiate a suitable group for OA prevention.
A recent RCT indicated exercise alone being as effective as
meniscectomy and exercise in relieving pain and improving func-
tion in patients with an MRI veriﬁed meniscal tear. A previous
study of arthroscopic debridement (including removal of menis-
cal tears) compared to lavage and sham surgery showed no
beneﬁt of surgery in patients with early OA. We thus have to
question the effect of surgery for meniscal tears and other early
intra-articular signs of OA and consider alternative treatment
options. These options include evidence-based treatments such
as exercise (and weight-loss for the overweight) for patients with
meniscal tears in order to improve pain and function with min-
imal risk of side effects. These treatments might also delay or
prevent OA. Additional randomized trials are needed to further
document the efﬁcacy of currently practised treatments of these
patients.
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Over the last few decades, the understanding of meniscal func-
tions and, consequently, the management of meniscal injuries,
has continued to evolve, with increasing commitment among
physicians to preserving the meniscus whenever possible. The
natural history of a meniscus-deﬁcient knee has been shown to
involve poor clinical and radiological outcomes over time, includ-
ing disruption of load-sharing and shock absorption, diminution
of joint stability, and deterioration of articular cartilage with pro-
gression to arthrosis.
The incongruency between the round femoral condyle and the
ﬂat tibial plateau is adapted by the meniscus. After removal of the
meniscus, the femorotibial contact area is largely reduced and
the peak stress on the articular cartilage considerably increased.
When confronted with an irreparable tear, substitution of the lost
tissue with a meniscus allograft or scaffold is gaining interest.
In order to improve our understanding of the meniscus function,
a better knowledge of the cellular biology of both the normal
meniscus as well as the transplanted meniscus is mandatory. Af-
ter all, the biomechanical behaviour of the meniscus (transplant)
is dictated by the cells residing within the tissue.
As more and more data is accumulated on the cells of the
normal meniscus, we now are aware that this ﬁbrocartilagenous
tissue has a unique architecture laid down by a number of
speciﬁc cells. Additionally, new insights are created based on
observations on cellular repopulation processes after meniscus
allograft transplantation. Better understanding the biomechanics
and biology of the meniscus should make us evolve towards a
